Studies by Uruno et al. in murine models of Nrf2 over-expression via both genetic Keap1 knockdown and pharmacological induction suggest that Nrf2 activation can improve insulin sensitivity in diabetes and abrogate diabetes and obesity in mice [44]. The gene discussed is KEAP1; the disease is diabetes mellitus.